首页> 美国卫生研究院文献>Scientific Reports >Bioimpedance-defined overhydration predicts survival in end stage kidney failure (ESKF): systematic review and subgroup meta-analysis
【2h】

Bioimpedance-defined overhydration predicts survival in end stage kidney failure (ESKF): systematic review and subgroup meta-analysis

机译:生物阻抗定义的过度水化可预测终末期肾衰竭(ESKF)的生存:系统评价和亚组荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Both overhydration and comorbidity predict mortality in end-stage kidney failure (ESKF) but it is not clear whether these are independent of one another. We undertook a systematic review of studies reporting outcomes in adult dialysis patients in which comorbidity and overhydration, quantified by whole body bioimpedance (BI), were reported. PubMed, EMBASE, PsychInfo and the Cochrane trial database were searched (1990–2017). Independent reviewers appraised studies including methodological quality (assessed using QUIPS). Primary outcome was mortality, with secondary outcomes including hospitalisation and cardiovascular events. Of 4028 citations identified, 46 matched inclusion criteria (42 cohorts; 60790 patients; 8187 deaths; 95% haemodialysis/5% peritoneal dialysis). BI measures included phase angle/BI vector (41%), overhydration index (39%) and extra:intracellular water ratio (20%). 38 of 42 cohorts had multivariable survival analyses (MVSA) adjusting for age (92%), gender (66%), diabetes (63%), albumin (58%), inflammation (CRP/IL6–37%), non-BI nutritional markers (24%) and echocardiographic data (8%). BI-defined overhydration (BI-OH) independently predicted mortality in 32 observational cohorts. Meta-analysis revealed overhydration >15% (HR 2.28, 95% CI 1.56–3.34, P < 0.001) and a 1-degree decrease in phase angle (HR 1.74, 95% CI 1.37–2.21, P < 0.001) predicted mortality. BI-OH predicts mortality in dialysis patients independent of the influence of comorbidity.
机译:过度饮水和合并症均可预测终末期肾衰竭(ESKF)的死亡率,但尚不清楚它们是否彼此独立。我们对报告成人透析患者结局的研究进行了系统的回顾,其中报道了合并症和水合作用过度(通过全身生物阻抗(BI)量化)。检索了PubMed,EMBASE,PsychInfo和Cochrane试验数据库(1990-2017年)。独立评审员评估了包括方法学质量在内的研究(使用QUIPS进行了评估)。主要结果是死亡率,次要结果包括住院和心血管事件。在4028篇文献中,有46篇符合纳入标准(42例; 60790例患者; 8187例死亡; 95%血液透析/ 5%腹膜透析)。 BI测量包括相角/ BI向量(41%),水合指数(39%)和细胞外水比(20%)。 42例队列中的38例进行了多变量生存分析(MVSA),调整了年龄(92%),性别(66%),糖尿病(63%),白蛋白(58%),炎症(CRP / IL6-37%),非BI营养指标(24%)和超声心动图数据(8%)。 BI定义的过度水化(BI-OH)独立预测了32个观察性队列的死亡率。荟萃分析显示,过度水合作用> 15%(HR 2.28,95%CI 1.56-3.34,P <0.001)和相角降低1度(HR 1.74,95%CI 1.37–2.21,P <0.001)预测死亡率。 BI-OH可以独立于合并症的影响来预测透析患者的死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号